USE OF BENZYDAMINE IN THE TREATMENT OF P40-DEPENDENT DISEASES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120302618A1
SERIAL NO

13382450

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Use of benzydamine in the treatment of inflammatory diseases, in particular Crohn's disease, rheumatoid arthritis, psoriatic arthritis, and psoriasis, caused by an expression or overexpression of the cytokine subunit p40.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A C R A F S P A00181 ROMA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Biondi, Enrica Nerviano (MI), IT 3 4
Biondi, Giuseppe Castel Gandolfo (Roma), IT 22 28
Biondi, Iacopo Castellanza (VA), IT 3 4
Guglielmotti, Angelo Roma, IT 27 126
Mangano, Giorgina Roma, IT 25 84
Petrosemolo, Roberta Castel Gandolfo (Roma), IT 3 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation